A phase 3 study found that the 20-valent pneumococcal conjugate vaccine (PCV20) elicited strong immune responses across all 20 serotypes and had a safety profile comparable with PCV13.
A phase 3 trial evaluating apremilast in children and adolescents with moderate-to-severe plaque psoriasis showed improvements in disease severity compared with placebo over 16 weeks.
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
Crinecerfont, a first-in-class therapy, improved androgen control and reduced reliance on high-dose glucocorticoids for patients with congenital adrenal hyperplasia.
In a study of more than 600,000 pediatric patients, researchers found a higher risk of type 2 diabetes within 6 months of a COVID-19 diagnosis compared with other respiratory infections, especially among...
A recent study found that single-dose intraoperative methadone reduced opioid consumption in children undergoing tonsillectomy compared with fentanyl, with no impact on postoperative pain scores or serious...
In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...
A randomized controlled trial assessed the efficacy of a novel gamified digital intervention in reducing ADHD symptoms and improving executive function in school-aged children, suggesting promising...
